US Patent 10344033 2-aminoquinazoline derivatives as P70S6 kinase inhibitors
Patent 10344033 was granted and assigned to Sentinel Oncology Limited on July, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10344033 2-aminoquinazoline derivatives as P70S6 kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.